Hu, S.-J.; Cheng, G.; Zhou, H.; Zhang, Q.; Zhang, Q.-L.; Wang, Y.; Shen, Y.; Lian, C.-X.; Ma, X.-Q.; Zhang, Q.-Y.;
et al. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects. Molecules 2022, 27, 702.
https://doi.org/10.3390/molecules27030702
AMA Style
Hu S-J, Cheng G, Zhou H, Zhang Q, Zhang Q-L, Wang Y, Shen Y, Lian C-X, Ma X-Q, Zhang Q-Y,
et al. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects. Molecules. 2022; 27(3):702.
https://doi.org/10.3390/molecules27030702
Chicago/Turabian Style
Hu, Si-Jing, Gang Cheng, Hao Zhou, Qi Zhang, Quan-Long Zhang, Yang Wang, Yi Shen, Chen-Xia Lian, Xue-Qin Ma, Qiao-Yan Zhang,
and et al. 2022. "Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects" Molecules 27, no. 3: 702.
https://doi.org/10.3390/molecules27030702
APA Style
Hu, S.-J., Cheng, G., Zhou, H., Zhang, Q., Zhang, Q.-L., Wang, Y., Shen, Y., Lian, C.-X., Ma, X.-Q., Zhang, Q.-Y., & Qin, L.-P.
(2022). Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects. Molecules, 27(3), 702.
https://doi.org/10.3390/molecules27030702